These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 32553895)

  • 101. Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.
    Li DG; Singer S; Mostaghimi A
    JAMA Dermatol; 2019 Apr; 155(4):460-464. PubMed ID: 30698625
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Author Disclosures in Plastic Surgery Journals Compared With Information Reported in the Open Payments Database: How Open Are We?
    Boyll P; Neville M; Bernard R; Mahabir RC
    Aesthet Surg J; 2019 Feb; 39(3):338-342. PubMed ID: 30256895
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Reporting of Financial Conflicts of Interest in Studies of Placental Membrane Allografts.
    Tian T; Zaepfel C; Bloom J; Alnahhal K; Chatterjee A; Allison GM; Iafrati M; Salehi P
    Adv Wound Care (New Rochelle); 2022 May; 11(5):226-233. PubMed ID: 34235968
    [No Abstract]   [Full Text] [Related]  

  • 104. Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database.
    Ozieranski P; Saghy E; Mulinari S
    PLoS One; 2023; 18(11):e0290022. PubMed ID: 37910526
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Conflicts of Interest in Clinical Guidelines: Lack of Authors and Disclosures in the AAOMS White Papers.
    Ji YD; Lahey ET
    J Oral Maxillofac Surg; 2018 Sep; 76(9):1946-1949. PubMed ID: 29577870
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Hepatic Ablation Technology: Assessment of Conflicts of Interest in Recent Literature.
    Kooragayala K; Moccia MC; Spitz F; Lenart A; Gandhi TV; Koneru M; Hong Y
    Am Surg; 2024 Jun; 90(6):1497-1500. PubMed ID: 38557117
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Undisclosed payments by pharmaceutical manufacturers to authors of inflammatory bowel disease guidelines in the United States.
    Al Sulais E; Alsahafi M; AlAmeel T
    Saudi J Gastroenterol; 2021; 27(6):342-347. PubMed ID: 34755712
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Observational study of financial and non-financial conflicts of interest among the Japanese government advisory board members concerning coronavirus disease 2019.
    Mamada H; Murayama A; Ozaki A; Hashimoto T; Saito H; Sawano T; Yamashita E; Bhandari D; Shrestha S; Tanimoto T
    Medicine (Baltimore); 2023 Jan; 102(4):e32776. PubMed ID: 36705373
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational study.
    Moriarty F; Larkin J; Fahey T
    Health Policy; 2021 Oct; 125(10):1297-1304. PubMed ID: 34429238
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Requesting conflicts of interest declarations from the European Medicines Agency: 3-year follow-up status.
    Boesen K; Gøtzsche PC; Ioannidis JPA
    Epidemiol Psychiatr Sci; 2024 Mar; 33():e17. PubMed ID: 38529624
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016).
    Ozieranski P; Csanádi M; Rickard E; Mulinari S
    BMJ Open; 2020 Sep; 10(9):e037351. PubMed ID: 32950962
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.
    Nalleballe K; Sheng S; Li C; Mahashabde R; Annapureddy AR; Mudassar K; Pothineni K; Veerapaneni P; Harada Y; Chilkulwar A; Ranabothu S; Brown A; Kapoor N; Onteddu S
    Stroke; 2020 Apr; 51(4):1339-1343. PubMed ID: 32078482
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Characteristics of Advanced Practice Nurses Receiving Top Industry Payments and Their Practice Settings: a Cross-sectional Study.
    Grundy Q; Held F; Hart D; Baugh CM; Ladd E; Campbell E; Bero L
    J Gen Intern Med; 2024 May; 39(7):1142-1148. PubMed ID: 37962732
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment.
    Hwong AR; Sah S; Lehmann LS
    J Gen Intern Med; 2017 Nov; 32(11):1186-1192. PubMed ID: 28717899
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Cross-sectional analysis of financial relationships between board certified allergists and the pharmaceutical industry in Japan.
    Murayama A; Senoo Y
    BMC Med Ethics; 2024 Feb; 25(1):22. PubMed ID: 38378633
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Drug company payments to General Practices in England: Cross-sectional and social network analysis.
    Saghy E; Mulinari S; Ozieranski P
    PLoS One; 2021; 16(12):e0261077. PubMed ID: 34874975
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Effect of the public disclosure of industry payments information on patients: results from a population-based natural experiment.
    Kanter GP; Carpenter D; Lehmann L; Mello MM
    BMJ Open; 2019 Mar; 9(2):e024020. PubMed ID: 30826793
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Editorial boards of dermatology journals and their potential financial conflict of interest.
    Updyke KM; Niu W; St Claire C; Schlager E; Knabel M; Leader NF; Sacotte RM; Dunnick CA; Dellavalle RP
    Dermatol Online J; 2018 Aug; 24(8):. PubMed ID: 30677845
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Assessment of Financial Conflicts of Interest Related to the Use of Dermal Substitutes in Burn Management.
    Radparvar J; Tian T; Karamchandani M; Aalberg J; Driscoll D; Homsy C; Chatterjee A
    J Burn Care Res; 2022 May; 43(3):586-591. PubMed ID: 34318879
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020.
    Murayama A; Saito H; Tanimoto T; Ozaki A
    J Eval Clin Pract; 2023 Sep; 29(6):883-886. PubMed ID: 37283452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.